It is better for your health to begin HIV treatment sooner, rather than later. There are some fixed-dose pills that combine two or three antiretroviral drugs from more than one drug class. These allow ...

He said, “Viraday is very patient friendly, as it requires just one pill a day and freedom from the severe side effect of many other anti HIV drugs.” The innovative treatment kits and the 3-in ...

A small French biotech is trumpeting results from a trial suggesting its developmental drug could be used as part of an HIV cure. The phase 2a trial of AbiVax’s ABX464 pill is small but confirms ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found. The strategy could also help stop the spread ...

Janssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient adherence and resistance to treatment. Symtuza (D/C/F/TAF) combines Janssen’s ...

Once a day, Tim Lagman takes a pill that reduces his risk of contracting HIV, a precaution he's taken since 2017. Pre-exposure prophylaxis, or PrEP, is part of the daily routine for a growing ...

The FDA just approved a new treatment for HIV. Genvoya, a combination pill developed by Gilead Sciences Inc. that only has to be taken once a day, is the first if its kind to get the agency's ...

Public health experts credit PrEP for declines in new HIV infections, about 32,000 in 2022. The treatment, available as daily ...

The FDA just approved a new combination of drugs to treat HIV. The treatment combines three drugs into one daily pill: bictegravir, emtricitabine and tenofovir alafenamide. The new approval could ...

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...